A dual RPA-LFD assay for the simultaneous detection of Salmonella typhimurium and Salmonella enteritidis

Chuan Liao, Lele Pan, Meiying Tan, Zihan Zhou, Shaoping Long, Xueli Yi, Xuebin Li, Guijiang Wei, Lina LiangFrontiers in Bioengineering and Biotechnology 2024 · DOI

This paper presents a significant step forward in rapid food safety and clinical diagnostics by introducing a dual-target isothermal amplification assay. By combining Recombinase Polymerase Amplification (RPA) with a Lateral Flow Dipstick (LFD), the researchers developed a method to simultaneously detect the two most common Salmonella serotypes in under 65 minutes at a constant temperature of 38°C.

TL;DR

Researchers have developed a "naked-eye" readable test that simultaneously identifies Salmonella typhimurium and Salmonella enteritidis without the need for expensive laboratory equipment. Operating at near-body temperature, this dual RPA-LFD assay matches the accuracy of gold-standard methods while being significantly faster and field-deployable.

What Problem Does This Paper Address?

Salmonella remains a leading cause of foodborne illness globally, with S. typhimurium and S. enteritidis accounting for over 75% of human infections. Rapidly identifying these specific strains is crucial for both clinical treatment and tracing the source of outbreaks.

However, current diagnostic options face a "Goldilocks" problem:

  • Culture-based methods are highly accurate but take days to yield results.
  • PCR (Polymerase Chain Reaction) is fast but requires expensive thermal cyclers and stable electricity, making it difficult to use in field settings or resource-poor clinics.
  • LAMP (Loop-mediated Isothermal Amplification) is isothermal but often suffers from high false-positive rates and complex primer design.

The authors sought a "just right" solution: a test that is as fast as PCR, as simple as a pregnancy test, and capable of detecting two different pathogens in a single reaction.

Methods

The authors utilized a combination of two powerful technologies:

  1. Recombinase Polymerase Amplification (RPA): This is the "isothermal" engine of the test. Unlike PCR, which uses heat to separate DNA strands, RPA uses a recombinase enzyme to pair primers with target DNA at a constant temperature (37°C–42°C). A strand-displacing polymerase then handles the amplification.
  2. Lateral Flow Dipstick (LFD): This provides the visual readout. By labeling the primers with specific molecules (Biotin, Digoxin, or FAM), the amplified DNA products are captured by antibodies on a paper strip, creating visible red bands.

The "Dual" Innovation: The team designed specific primer sets for the STM4497 gene (specific to S. typhimurium) and the safA gene (specific to S. enteritidis). By using different molecular labels for each target, they enabled the LFD to display two distinct test lines (T1 and T2) plus a control line in a single strip.

Datasets

The study validated the assay using three types of samples:

  • Standard Strains: A panel of ATCC strains including Salmonella and common "look-alike" pathogens (E. coli, K. pneumoniae, etc.) to ensure no cross-reactivity.
  • Artificially Contaminated Samples: Stool samples spiked with known concentrations of bacteria to determine the Limit of Detection (LOD) in a complex biological matrix.
  • Clinical Specimens: 25 real-world stool samples from the Affiliated Hospital of Youjiang Medical University for Nationalities. Results were compared against the Bacterial Analysis Manual (BAM), the traditional gold-standard culture method.

Key Insights and Ideas

  • Body-Temperature Operation: The assay's optimal temperature is 38°C. This is significant because it suggests the test could potentially be incubated using basic heat packs or even body heat in extreme field conditions.
  • Overcoming Matrix Interference: Stool is a notoriously difficult sample type for molecular tests because it contains inhibitors that can stall chemical reactions. The authors demonstrated that while the detection limit is slightly higher in stool than in pure culture, it remains sensitive enough for clinical relevance.
  • Primer Ratio Optimization: A key challenge in "multiplex" (multi-target) reactions is that one target might amplify faster than the other, masking the second result. The authors spent significant effort optimizing the primer ratios to ensure both Salmonella strains could be detected simultaneously with equal clarity.

Key Results

  • Speed: The entire process—from DNA extraction to visual result—takes approximately 65 minutes.
  • Sensitivity: The Limit of Detection (LOD) in stool was 83.0 CFU/mL for S. typhimurium and 270 CFU/mL for S. enteritidis.
  • Accuracy: In clinical testing, the assay achieved 100% sensitivity and 100% specificity, perfectly matching the results of the much slower BAM culture method.
  • Specificity: The test showed zero cross-reactivity with other common intestinal pathogens.

Limitations and Future Work

While the assay is highly effective, the authors and the methodology suggest a few areas for improvement:

  • The Extraction Bottleneck: Although the amplification and detection are fast, the initial DNA extraction still takes about 30 minutes and requires a separate kit. Future iterations might look toward "extraction-free" methods or integrated microfluidic devices.
  • Aerosol Contamination: RPA is so sensitive that opening a reaction tube to run the LFD can occasionally lead to lab contamination with amplified DNA. Moving toward a "closed-chamber" LFD system would enhance reliability.
  • Quantification: Like most LFD tests, this is a binary "yes/no" result. It does not tell the user exactly how much bacteria is present, which can be important for certain clinical assessments.

Overall, this dual RPA-LFD assay represents a robust, low-cost tool for decentralized testing, moving high-quality diagnostics out of the central lab and closer to the point of need.

Summary updated

Abstract

<b>Introduction:</b> <i>Salmonella</i> was one of the most common bacteria that caused foodborne illness, with <i>S. typhimurium</i> (<i>Salmonella typhimurium</i>) and <i>S. enteritidis</i> (<i>Salmonella enteritidis</i>) infections accounting for more than 75% of human salmonella infections. <b>Methods:</b> In this study, we developed a method of dual recombinase polymerase amplification (RPA) combined with a lateral flow dipstick for the rapid detection of <i>S. typhimurium</i> and <i>S. enteritidis</i> in clinical specimens (stool). <b>Results:</b> The entire reaction process, including amplification and result reading, could be completed within 65 min. The detection limits of <i>S. typhimurium</i> and <i>S. enteritidis</i> in pure culture samples were 5.23 × 10<sup>1</sup> CFU/mL and 3.59 × 10<sup>1</sup> CFU/mL, respectively. The detection limits of <i>S. typhimurium</i> and <i>S. enteritidis</i> in artificially contaminated samples were 8.30 × 10<sup>1</sup> CFU/mL and 2.70 × 10<sup>2</sup> CFU/mL, respectively. In addition, the method had no cross-reaction with other pathogenic microorganisms. The results in clinical samples were fully consistent with those obtained using Bacterial Analysis Manual, with sensitivity and specificity were 100% (8/8) and 100% (17/17) for <i>S. typhimurium</i> and 100% (4/4) and 100% (21/21) for <i>S. enteritidis</i>, respectively. <b>Discussion:</b> The detection limits of <i>S. typhimurium</i> and <i>S. enteritidis</i> in artificially contaminated samples were higher than those in pure culture samples, which might be attributed to the inherent complex composition of artificially contaminated samples. In addition, the detection limits of <i>S. typhimurium</i> and <i>S. enteritidis</i> in the same sample were also different, which might be attributed to different amplification efficiency of two target genes in the same reaction system. <b>Conclusion:</b> This assay had potential application outdoors, as it could be performed within 1 h at 38°C without a complex instrument, and the results could be observed with the naked eye. In conclusion, the dual RPA-LFD assay established in this study had practical significance for the rapid detection of <i>S. typhimurium</i> and <i>S. enteritidis</i> in the future.
BibTeX
@inproceedings{liao2024dual,
  author = {Chuan Liao and Lele Pan and Meiying Tan and Zihan Zhou and Shaoping Long and Xueli Yi and Xuebin Li and Guijiang Wei and Lina Liang},
  title = {{A dual RPA-LFD assay for the simultaneous detection of Salmonella typhimurium and Salmonella enteritidis}},
  booktitle = {Frontiers in Bioengineering and Biotechnology},
  year = {2024},
  doi = {10.3389/fbioe.2024.1379939},
}
Figure